Literature DB >> 2172782

Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant.

R Wisdom1, I M Verma.   

Abstract

Phenotypic revertants of Finkel-Biskis-Riley (FBR)-murine sarcoma virus-transformed rat fibroblasts were isolated on the basis of their adherence to plastic tissue culture dishes in the absence of divalent cations. Some revertants had sustained deletions or inactivating mutations of the v-fos gene. However, two revertants expressed a functional v-fos gene at levels equal to that in the transformed parental cells, and therefore phenotypic reversion was due to mutations in nonviral genes. These revertants were considered nontransformed according to four criteria: (i) they were flat and had a nontransformed morphology, (ii) they were contact inhibited when grown to confluence, (iii) they did not display anchorage-independent growth in soft agar, and (iv) they did not form tumors in nude mice. Somatic-cell hybrids between the revertants and the transformed parental cells were nontransformed, suggesting that the revertants had sustained an activating mutation of a gene capable of suppressing transformation. The expression of c-jun, junB, and junD was not altered in the revertants, and they could not be transformed by transfection with a c-jun expression vector. The revertants were resistant to transformation by an activated c-Ha-ras gene but were susceptible to transformation by simian virus 40. Our results demonstrate the existence of a class of revertants that harbor genes capable of suppressing transformation by v-fos and some other oncogenes. This contrasts with previously described revertants of transformation by v-fos that contain recessive mutations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172782      PMCID: PMC361322          DOI: 10.1128/mcb.10.11.5626-5633.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  A ras-related gene with transformation suppressor activity.

Authors:  H Kitayama; Y Sugimoto; T Matsuzaki; Y Ikawa; M Noda
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  A gene activated by growth factors is related to the oncogene v-jun.

Authors:  K Ryder; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.

Authors:  J R Haynes; J R Downing
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

4.  Transcriptional autoregulation of the proto-oncogene fos.

Authors:  P Sassone-Corsi; J C Sisson; I M Verma
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

5.  The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.

Authors:  R Chiu; W J Boyle; J Meek; T Smeal; T Hunter; M Karin
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

6.  fos-associated cellular p39 is related to nuclear transcription factor AP-1.

Authors:  P Sassone-Corsi; W W Lamph; M Kamps; I M Verma
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

Review 7.  Fos-associated protein p39 is the product of the jun proto-oncogene.

Authors:  F J Rauscher; D R Cohen; T Curran; T J Bos; P K Vogt; D Bohmann; R Tjian; B R Franza
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

8.  jun-D: a third member of the jun gene family.

Authors:  K Ryder; A Lanahan; E Perez-Albuerne; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation.

Authors:  M Schuermann; M Neuberg; J B Hunter; T Jenuwein; R P Ryseck; R Bravo; R Müller
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

10.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

View more
  6 in total

1.  Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells.

Authors:  V Lavrovsky; Z Dong; W Y Ma; N Colburn
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

2.  Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation.

Authors:  R Wisdom; I M Verma
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

3.  Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci.

Authors:  T H Chen; J R Brody; F E Romantsev; J G Yu; A E Kayler; E Voneiff; F P Kuhajda; G R Pasternack
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

4.  Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria.

Authors:  C J Kho; H Zarbl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.

Authors:  R S Krauss; S N Guadagno; I B Weinstein
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

6.  Transformation by Fos proteins requires a C-terminal transactivation domain.

Authors:  R Wisdon; I M Verma
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.